Clinical trial · Observational
Non Invasive Cancer Test (NICT): a Proof of Principle Study.
NCT03019471CI-TRIAL-00096365NICT-NIPT-CArecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators aim to collect tumor DNA out of blood of cancer patients. If this is successful this could lead to the development of a cancer test in blood in the future, which is less invasive than current diagnostic methods.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasmata | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Isolation of tumor DNA | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Lung cancer
- description
- Isolate Tumor DNA from the patients blood.
- interventionNames
- Genetic: Isolation of tumor DNA
- label
- Breast cancer
- description
- Isolate Tumor DNA from the patients blood.
- interventionNames
- Genetic: Isolation of tumor DNA
- label
- Colorectal cancer
- description
- Isolate Tumor DNA from the patients blood.
- interventionNames
- Genetic: Isolation of tumor DNA
- label
- Glioma
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with newly diagnosed local or metastatic breast cancer, colorectal cancer, non-small cell lung cancer and anaplastic glioblastoma, before start of radiation therapy, chemoradiation or chemotherapy. 2. Patients age \> 18 years, willing and able to comply with the protocol as judged by the investigator with a signed informed consent Exclusion Criteria: 1. Patients with a history of malignant disease other than the disease under study, with an exception for adequately treated squamous cell carcinoma of the skin, basal cell carcinoma of the skin and in situ cervix carcinoma. 2. Pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.